审查预测shikonin作为女性癌症的治疗候选者:临床前的视角
Pratibha Pandey1, Sorabh Lakhanpal2, K V Jamuna3
1Research and Innovation Cell, Rayat Bahra University, Mohali, Punjab, India.
Frontiers in pharmacology
|July 21, 2025
概括
石素是Lithospermum erythrorhizon中的一种化合物,通过影响细胞死亡,生长和新陈代谢,显示出抗癌承诺. 需要进一步的临床试验来确认其在治疗女性癌症中的有效性和安全性.
科学领域:
- 自然产品 化学 化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 来自Lithospermum erythrorhizon的一种纳夫托基诺尼,Shikonin,正在研究其抗癌性质.
- 它表现出各种抗癌活性,包括诱导亡,自和DNA损伤,并抑制血管生成.
研究的目的:
- 探索石康宁作为癌症治疗剂的潜力,特别是在女性癌症中.
- 了解其在新陈代谢重编程中的作用和与传统疗法的协同效应.
主要方法:
- 对希科宁抗癌活性现有研究的文献综述.
- 关于希科宁疗效的初步临床试验数据的分析.
主要成果:
- 石康宁显示出广泛的抗癌作用,包括逆转耐药性和抑制癌细胞生长.
- 初步的临床试验表明,什科宁可以增强传统的癌症治疗方法,如化疗,放射和免疫疗法.
结论:
- 石康宁通过调节癌细胞代谢,显示出作为抗癌剂的显著潜力,特别是在女性癌瘤中.
- 进一步的机制研究和强大的临床试验对于确定其临床疗效,安全性和确定新的治疗点至关重要.
相关概念视频
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


